» Articles » PMID: 12504025

NEDD8 Modification of CUL1 Dissociates P120(CAND1), an Inhibitor of CUL1-SKP1 Binding and SCF Ligases

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Dec 31
PMID 12504025
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Cullin proteins assemble a large number of RING E3 ubiquitin ligases and regulate various physiological processes. Covalent modification of cullins by the ubiquitin-like protein NEDD8 activates cullin ligases through an as yet undefined mechanism. We show here that p120(CAND1) selectively binds to unneddylated CUL1 and is dissociated by CUL1 neddylation. CAND1 formed a ternary complex with CUL1 and ROC1. CAND1 dissociated SKP1 from CUL1 and inhibited SCF ligase activity in vitro. Suppression of CAND1 in vivo increased the level of the CUL1-SKP1 complex. We suggest that by restricting SKP1-CUL1 interaction, CAND1 regulated the assembly of productive SCF ubiquitin ligases, allowing a common CUL1-ROC core to be utilized by a large number of SKP1-F box-substrate subcomplexes.

Citing Articles

The small CRL4 ubiquitin ligase component DDA1 regulates transcription-coupled repair dynamics.

Llerena Schiffmacher D, Lee S, Kliza K, Theil A, Akita M, Helfricht A Nat Commun. 2024; 15(1):6374.

PMID: 39075067 PMC: 11286758. DOI: 10.1038/s41467-024-50584-7.


KCTD proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice.

Ding Z, Zhang C, Yang H, Chen J, Sun Z, Zhen X PLoS Biol. 2024; 22(7):e3002716.

PMID: 39008526 PMC: 11271871. DOI: 10.1371/journal.pbio.3002716.


Protein neddylation and its role in health and diseases.

Zhang S, Yu Q, Li Z, Zhao Y, Sun Y Signal Transduct Target Ther. 2024; 9(1):85.

PMID: 38575611 PMC: 10995212. DOI: 10.1038/s41392-024-01800-9.


CAND1 inhibits Cullin-2-RING ubiquitin ligases for enhanced substrate specificity.

Wang K, Diaz S, Li L, Lohman J, Liu X Nat Struct Mol Biol. 2024; 31(2):323-335.

PMID: 38177676 PMC: 10923007. DOI: 10.1038/s41594-023-01167-5.


ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.

Ao Y, Gao J, Jin C, Wang S, Zhang L, Deng J J Immunother Cancer. 2023; 11(12).

PMID: 38148115 PMC: 10753855. DOI: 10.1136/jitc-2023-007766.